Tag: iSchemaView
Although “unperfected”, AI has the potential to accelerate and synchronise stroke...
A recently published systematic review reveals that artificial intelligence (AI) is rapidly being used by major medical centres to identify large vessel occlusions (LVO)...
RAPID platform expands to address haemorrhagic stroke
iSchemaView has launched the newest addition to the RAPID platform, RAPID ICH at the 2019 Congress of Neurological Surgeons (CNS) Annual Meeting (19–23 October,...
Artis icono from Siemens Healthineers expands precision with improved visualisation in...
At the European Congress of Radiology (ECR; 27 February–3 March, Vienna, Austria) Siemens Healthineers will introduce the Artis icono biplane, an angiography system with...
iSchemaView’s RAPID approved for use in Brazil
iSchemaView receives approval from ANVISA (the Brazilian Health Regulatory Agency), for the use of the RAPID imaging platform across Brazil.
RAPID is designed to...
iSchemaView and NeuroLogica team up to mobilise stroke care worldwide
iSchemaView and NeuroLogica have announced a partnership to integrate iSchemaView’s RAPID cerebrovascular imaging platform with NeuroLogica’s portable CereTom computed tomography (CT) scanners for use...
iSchemaView RAPID integrates with Join, Allm’s medical communications platform
iSchemaView has announced that the RAPID platform is now compatible with Join, a medical communication app developed by Allm, a multinational developer of mobile...
iSchemaView completes MDSAP audit — moves to expand worldwide adoption of...
iSchemaView has announced that the company has completed the Medical Device Single Audit Program (MDSAP), with coming certification. iSchemaView is now applying for clearances...
State-of-the-art imaging solution provides automated scoring to assess early signs of...
At the European Stroke Organisation Conference, iSchemaView publicly launched RAPID ASPECTS, a digital imaging solution that assists clinicians in assessing early signs of brain...
RAPID CTA gets FDA clearance
iSchemaView has received final clearance from the US Food and Drug Administration (FDA) for RAPID CTA, the company’s 3D imaging solution for Computed Tomography...
